Ruboxistaurin Completed Phase 3 Trials for Type 1 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00297401Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus